Woebot Health
Woebot Health
Enterprise AI chatbot for mental health with FDA Breakthrough designation for postpartum depression.
About Woebot Health
Woebot Health is a clinical-grade AI mental health platform that uses a rule-based conversational chatbot (not generative AI) to deliver evidence-based therapeutic techniques including CBT, DBT, and IPT. The company received FDA Breakthrough Device Designation in 2021 for WB001, its investigational digital therapeutic for postpartum depression, and has been conducting pivotal clinical trials. In June 2025, Woebot discontinued its direct-to-consumer app to focus entirely on enterprise partnerships with payers, providers, and health systems. The platform is backed by 15+ randomized controlled trials showing effect sizes of d=0.57 for anxiety and d=0.46 for depression. Enterprise revenue comes from Per Member Per Month (PMPM) subscriptions and per-treatment cycle fees ($200-$450). Notable partnerships include Akron Children's Hospital for adolescent mental health. The 2025 Open Access API enables third-party healthcare apps to embed Woebot's conversational interface.
Best For
- • Health systems seeking AI-augmented mental health support
- • Payers implementing scalable behavioral health interventions
- • Pediatric hospitals providing adolescent mental health support
- • Employers wanting evidence-based digital mental health
Not Ideal For
- • Individual consumers (DTC app discontinued June 2025)
- • Solo practitioners
- • Organizations seeking traditional MBC assessment tools
- • Those wanting FDA-cleared products (still in trials for PPD)
Pricing
Contact for enterprise pricing
Compliance & Security
Always verify compliance directly with the vendor.
Target Audience
Roles
Settings
Related Tools
Koa Health
Clinical-first digital CBT platform with 7 DTx products backed by 21 clinical trials.
Happify Health / Twill (DarioHealth)
Configurable digital therapeutics for pharma, health plans, and employers - now part of DarioHealth.
Akili Interactive (EndeavorRx, EndeavorOTC)
First FDA-cleared video game digital therapeutic for ADHD in children and adults.
Big Health (Sleepio, Daylight)
First FDA-cleared DTx for anxiety (DaylightRx) and insomnia (SleepioRx) with Medicare coverage.